Lilly Pulitzer is serving up a Valentine’s Day partnership with Lele Sadoughi, the New York-based accessories brand. Marking ...

Coach embraces Pantone's Color of the Year with its Pebble Leather Chaise Crossbody Bag. Available at Amazon, the Coach bag ...

Harbor Capital Advisors Inc. boosted its position in Oxford Industries, Inc. (NYSE:OXM – Free Report) by 14.0% during the ...

Lilly Pulitzer’s treasured Sunshine Sale is back with splurge-worthy discounts and new styles perfect for the winter or ...

A long-sleeve blouse is a smart closet staple for polished outfits in a pinch — especially when it’s as cute as this one. Hundreds of shop ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for ... [+] health insurers, employers and government health programs who cover it in 2025.

Since Zepbound was approved by the FDA to treat obesity in late 2023, its maker Eli Lilly has been steadily closing in on fierce rival Novo Nordisk’s early lead in the obesity market.

Both Lilly and Novo Nordisk are experiencing unprecedented growth thanks to their weight loss medications. However, Lilly also treats cancer, plaque psoriasis, Alzheimer's disease, eczema ...

Jewelry can be just as important as clothing when it comes to curating a personal style. Although some aspects of the accessory are more personal and subjective — wedding bands, family heirlooms ...

Shares of Eli Lilly (NYSE:LLY) are down 7.6% today, reflecting market disappointment in the company's adjusted guidance for the fourth quarter of 2024. The pharmaceutical giant expects only $13.5 ...

Lilly seeks to protect interests in compounded drug case FDA affirms no shortage of tirzepatide drugs Compounded versions cheaper, often not covered by insurers Jan 2 (Reuters) - Eli Lilly (LLY.N ...